Related references
Note: Only part of the references are listed.Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification
Eva Musulen et al.
HUMAN PATHOLOGY (2013)
The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors
Cathrin Huth et al.
MODERN PATHOLOGY (2012)
Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion
Henry T. Lynch et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Characterization of New Founder Alu-Mediated Rearrangements in MSH2 Gene Associated with a Lynch Syndrome Phenotype
Lucia Perez-Cabornero et al.
CANCER PREVENTION RESEARCH (2011)
Recurrence and Variability of Germline EPCAM Deletions in Lynch Syndrome
Roland P. Kuiper et al.
HUMAN MUTATION (2011)
Analysis of EPCAM Protein Expression in Diagnostics of Lynch Syndrome
Matthias Kloor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases
Kandelaria Rumilla et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Marlies J. E. Kempers et al.
LANCET ONCOLOGY (2011)
MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families
Ester Borras et al.
CANCER RESEARCH (2010)
Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome
M. Menendez et al.
CLINICAL GENETICS (2010)
EPCAM Germ Line Deletions as Causes of Lynch Syndrome in Spanish Patients
Carla Guarinos et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Detection of genetic alterations in hereditary colorectal cancer screening
Marta Pineda et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
H. T. Lynch et al.
CLINICAL GENETICS (2009)
High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers
Eli Marie Grindedal et al.
FAMILIAL CANCER (2009)
Germline Hypermethylation of MLH1 and EPCAM Deletions Are a Frequent Cause of Lynch Syndrome
Renee C. Niessen et al.
GENES CHROMOSOMES & CANCER (2009)
Rare pathogenic microdeletions and tandem duplications are microhomology-mediated and stimulated by local genomic architecture
Lisenka E. L. M. Vissers et al.
HUMAN MOLECULAR GENETICS (2009)
Deletions Removing the Last Exon of TACSTD1 Constitute a Distinct Class of Mutations Predisposing to Lynch Syndrome
Marietta E. Kovacs et al.
HUMAN MUTATION (2009)
Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer
M. P. Hitchins et al.
JOURNAL OF MEDICAL GENETICS (2009)
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ' exons of TACSTD1
Marjolijn J. L. Ligtenberg et al.
NATURE GENETICS (2009)
New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife
Vicente Medina-Arana et al.
CANCER LETTERS (2006)
Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer
Tsun Leung Chan et al.
NATURE GENETICS (2006)
Polymorphisms in genes of nucleotide and base excision repair:: Risk and prognosis of colorectal cancer
V Moreno et al.
CLINICAL CANCER RESEARCH (2006)
A comparison of Bayesian methods for haplotype reconstruction from population genotype data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
JP Schouten et al.
NUCLEIC ACIDS RESEARCH (2002)
Share Paper
